ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.77 and traded as low as $4.02. ZIVO Bioscience shares last traded at $4.02, with a volume of 100 shares changing hands.
ZIVO Bioscience Price Performance
The business’s 50 day simple moving average is $4.17 and its 200-day simple moving average is $5.76. The stock has a market capitalization of $16.69 million, a P/E ratio of -0.82 and a beta of 0.14.
ZIVO Bioscience Company Profile
ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.
Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.
See Also
- Five stocks we like better than ZIVO Bioscience
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
